Nerhadou International for Pharmaceuticals and Nutraceuticals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nerhadou International for Pharmaceuticals and Nutraceuticals - overview
Established
1996
Location
6th of October, -, Egypt
Primary Industry
Pharmaceuticals
About
Based in Giza, Egypt, and founded in 1996 by CEO Mohsen Shalaby, Nerhadou International for Pharmaceuticals and Nutraceuticals provides pharmaceutical products for human nutrition, beauty, and health. In February 2022, Affirma Capital and StonePine Capital Partners agreed to acquire a minority stake in Nerhadou International for Pharmaceuticals and Nutraceuticals for USD 20 million. Nerhadou International for Pharmaceuticals and Nutraceuticals offers a diverse range of products, including multi-amino acid chelates, natural products, and oral dispersible films (ODF). These products are designed to cater to a wide spectrum of health and wellness needs, providing customers with effective solutions to enhance their well-being.
The company's use of mineral chelation stems from enhancing mineral bioavailability while minimising associated side effects. In this process, minerals are embedded within peptides, allowing for recognition and efficient absorption by the body. Chelation prevents the formation of insoluble mineral precipitates and facilitates optimal absorption of minerals at specific sites in the body.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.nerhadou.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Nerhadou International for Pharmaceuticals and Nutraceuticals - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Nerhadou International for Pharmaceuticals and Nutraceuticals | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.